Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

2.

Gender equity in mass drug administration for neglected tropical diseases: data from 16 countries.

Cohn DA, Kelly MP, Bhandari K, Zoerhoff KL, Batcho WE, Drabo F, Negussu N, Marfo B, Goepogui A, Lemoine JF, Ganefa S, Massangaie M, Rimal P, Gnandou I, Anagbogu IN, Ndiaye M, Bah YM, Mwingira UJ, Awoussi MS, Tukahebwa EM, Stelmach RD, Mingkwan PC, Pou B, Koroma JB, Rotondo LA, Kraemer JD, Baker MC.

Int Health. 2019 Mar 8. pii: ihz012. doi: 10.1093/inthealth/ihz012. [Epub ahead of print]

PMID:
30845318
3.

Completing Baseline Mapping of Trachoma in Uganda: Results of 14 Population-Based Prevalence Surveys Conducted in 2014 and 2018.

Baayenda G, Mugume F, Turyaguma P, Tukahebwa EM, Binagwa B, Onapa A, Agunyo S, Osilo MK, French MD, Thuo W, Rotondo LA, Renneker K, Willis R, Bakhtiari A, Harding-Esch EM, Solomon AW, Ngondi JM.

Ophthalmic Epidemiol. 2018 Dec;25(sup1):162-170. doi: 10.1080/09286586.2018.1546879.

4.

Paper-based microfluidics for DNA diagnostics of malaria in low resource underserved rural communities.

Reboud J, Xu G, Garrett A, Adriko M, Yang Z, Tukahebwa EM, Rowell C, Cooper JM.

Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):4834-4842. doi: 10.1073/pnas.1812296116. Epub 2019 Feb 19.

5.

Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, Uganda.

Elliott AM, Roestenberg M, Wajja A, Opio C, Angumya F, Adriko M, Egesa M, Gitome S, Mfutso-Bengo J, Bejon P, Kapulu M, Seager Z, Lutalo T, Nazziwa WB, Muwumuza A, Yazdanbakhsh M, Kaleebu P, Kabatereine N, Tukahebwa E.

AAS Open Res. 2018 Apr 18;1:2. doi: 10.12688/aasopenres.12841.1.

6.

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.

Wajja A, Namutebi M, Apule B, Oduru G, Kiwanuka S, Akello M, Nassanga B, Kabagenyi J, Mpiima J, Vermaak S, Lawrie A, Satti I, Verweij J, Cose S, Levin J, Kaleebu P, Tukahebwa E, McShane H, Elliott AM.

Wellcome Open Res. 2018 Sep 19;3:121. doi: 10.12688/wellcomeopenres.14736.1. eCollection 2018.

7.

Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test.

Bärenbold O, Garba A, Colley DG, Fleming FM, Haggag AA, Ramzy RMR, Assaré RK, Tukahebwa EM, Mbonigaba JB, Bucumi V, Kebede B, Yibi MS, Meité A, Coulibaly JT, N'Goran EK, Tchuem Tchuenté LA, Mwinzi P, Utzinger J, Vounatsou P.

PLoS Negl Trop Dis. 2018 Dec 14;12(12):e0006941. doi: 10.1371/journal.pntd.0006941. eCollection 2018 Dec.

8.

Author Correction: Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys.

Michael E, Smith ME, Katabarwa MN, Byamukama E, Griswold E, Habomugisha P, Lakwo T, Tukahebwa E, Miri ES, Eigege A, Ngige E, Unnasch TR, Richards FO.

Nat Commun. 2018 Nov 19;9(1):4929. doi: 10.1038/s41467-018-07507-0.

9.

Precision global health and comorbidity: a population-based study of 16 357 people in rural Uganda.

Chami GF, Kabatereine NB, Tukahebwa EM, Dunne DW.

J R Soc Interface. 2018 Oct 31;15(147). pii: 20180248. doi: 10.1098/rsif.2018.0248.

10.

Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys.

Michael E, Smith ME, Katabarwa MN, Byamukama E, Griswold E, Habomugisha P, Lakwo T, Tukahebwa E, Miri ES, Eigege A, Ngige E, Unnasch TR, Richards FO.

Nat Commun. 2018 Oct 18;9(1):4324. doi: 10.1038/s41467-018-06657-5. Erratum in: Nat Commun. 2018 Nov 19;9(1):4929.

11.

Low Praziquantel Treatment Coverage for Schistosoma mansoni in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance.

Adriko M, Faust CL, Carruthers LV, Moses A, Tukahebwa EM, Lamberton PHL.

Trop Med Infect Dis. 2018 Oct 8;3(4). pii: E111. doi: 10.3390/tropicalmed3040111.

12.

Schistosoma mansoni-Associated Morbidity among Preschool-Aged Children along the Shores of Lake Victoria in Uganda.

Nalugwa A, Nuwaha F, Tukahebwa EM, Olsen A.

Trop Med Infect Dis. 2017 Nov 5;2(4). pii: E58. doi: 10.3390/tropicalmed2040058.

13.

Antibody responses to Schistosoma mansoni schistosomula antigens.

Egesa M, Lubyayi L, Jones FM, van Diepen A, Chalmers IW, Tukahebwa EM, Bagaya BS, Hokke CH, Hoffmann KF, Dunne DW, Elliott AM, Yazdanbakhsh M, Wilson S, Cose S.

Parasite Immunol. 2018 Dec;40(12):e12591. doi: 10.1111/pim.12591. Epub 2018 Oct 14.

14.

Schistosoma mansoni schistosomula antigens induce Th1/Pro-inflammatory cytokine responses.

Egesa M, Lubyayi L, Tukahebwa EM, Bagaya BS, Chalmers IW, Wilson S, Hokke CH, Hoffmann KF, Dunne DW, Yazdanbakhsh M, Labuda LA, Cose S.

Parasite Immunol. 2018 Dec;40(12):e12592. doi: 10.1111/pim.12592. Epub 2018 Oct 21.

15.

Data on the pre-MDA and post MDA interventions for Schistosoma mansoni and Schistosoma haematobium in a co-endemic focus in Uganda: 1951-2011.

Adriko M, Tinkitina B, Tukahebwa EM, Standley CJ, Stothard JR, Kabatereine NB.

Data Brief. 2018 Sep 6;20:991-998. doi: 10.1016/j.dib.2018.08.200. eCollection 2018 Oct.

16.

The impact of intensive versus standard anthelminthic treatment on allergy-related outcomes, helminth infection intensity and helminth-related morbidity in Lake Victoria fishing communities, Uganda: results from the LaVIISWA cluster randomised trial.

Sanya RE, Nkurunungi G, Hoek Spaans R, Nampijja M, O'Hara G, Kizindo R, Oduru G, Kabuubi Nakawungu P, Niwagaba E, Abayo E, Kabagenyi J, Zziwa C, Nakazibwe E, Tumusiime J, Kaweesa J, Muwonge Kakooza F, Akello M, Lubyayi L, Verweij J, Nash S, van Ree R, Mpairwe H, Tukahebwa E, Webb EL, Elliott AM; LaVIISWA trial team.

Clin Infect Dis. 2018 Sep 8. doi: 10.1093/cid/ciy761. [Epub ahead of print]

17.

Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.

Jacob BG, Loum D, Lakwo TL, Katholi CR, Habomugisha P, Byamukama E, Tukahebwa E, Cupp EW, Unnasch TR.

PLoS Negl Trop Dis. 2018 Aug 27;12(8):e0006702. doi: 10.1371/journal.pntd.0006702. eCollection 2018 Aug.

18.

After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight.

Katabarwa MN, Lakwo T, Habomugisha P, Unnasch TR, Garms R, Hudson-Davis L, Byamukama E, Khainza A, Ngorok J, Tukahebwa E, Richards FO.

Int Health. 2018 Mar 1;10(suppl_1):i79-i88. doi: 10.1093/inthealth/ihx044.

PMID:
29471335
19.

"Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013".

Lakwo T, Ukety T, Bakajika D, Tukahebwa E, Awaca P, Amazigo U.

Global Health. 2018 Feb 6;14(1):16. doi: 10.1186/s12992-018-0333-1.

20.

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda.

Prada JM, Touloupou P, Adriko M, Tukahebwa EM, Lamberton PHL, Hollingsworth TD.

Parasit Vectors. 2018 Jan 8;11(1):21. doi: 10.1186/s13071-017-2580-z.

21.

The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.

Luroni LT, Gabriel M, Tukahebwa E, Onapa AW, Tinkitina B, Tukesiga E, Nyaraga M, Auma AM, Habomugisha P, Byamukama E, Oguttu D, Katabarwa M, Unnasch TR.

PLoS One. 2017 Dec 18;12(12):e0189306. doi: 10.1371/journal.pone.0189306. eCollection 2017.

22.

Interpreting ambiguous 'trace' results in Schistosoma mansoni CCA Tests: Estimating sensitivity and specificity of ambiguous results with no gold standard.

Clements MN, Donnelly CA, Fenwick A, Kabatereine NB, Knowles SCL, Meité A, N'Goran EK, Nalule Y, Nogaro S, Phillips AE, Tukahebwa EM, Fleming FM.

PLoS Negl Trop Dis. 2017 Dec 8;11(12):e0006102. doi: 10.1371/journal.pntd.0006102. eCollection 2017 Dec.

23.

Diffusion of treatment in social networks and mass drug administration.

Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, Dunne DW.

Nat Commun. 2017 Dec 5;8(1):1929. doi: 10.1038/s41467-017-01499-z.

24.

Rapid clearance of Schistosoma mansoni circulating cathodic antigen after treatment shown by urine strip tests in a Ugandan fishing community - Relevance for monitoring treatment efficacy and re-infection.

Kildemoes AO, Vennervald BJ, Tukahebwa EM, Kabatereine NB, Magnussen P, de Dood CJ, Deelder AM, Wilson S, van Dam GJ.

PLoS Negl Trop Dis. 2017 Nov 13;11(11):e0006054. doi: 10.1371/journal.pntd.0006054. eCollection 2017 Nov.

25.

Evaluation of Community-Directed Operation of Black Fly Traps for Entomological Surveillance of Onchocerca volvulus Transmission in the Madi-Mid North Focus of Onchocerciasis in Northern Uganda.

Loum D, Katholi CR, Lakwo T, Habomugisha P, Tukahebwa EM, Unnasch TR.

Am J Trop Med Hyg. 2017 Oct;97(4):1235-1242. doi: 10.4269/ajtmh.17-0244.

26.

Social network fragmentation and community health.

Chami GF, Ahnert SE, Kabatereine NB, Tukahebwa EM.

Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7425-E7431. doi: 10.1073/pnas.1700166114. Epub 2017 Jul 24.

27.

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.

Wajja A, Kizito D, Nassanga B, Nalwoga A, Kabagenyi J, Kimuda S, Galiwango R, Mutonyi G, Vermaak S, Satti I, Verweij J, Tukahebwa E, Cose S, Levin J, Kaleebu P, Elliott AM, McShane H.

PLoS Negl Trop Dis. 2017 May 4;11(5):e0005440. doi: 10.1371/journal.pntd.0005440. eCollection 2017 May.

28.

Community-directed mass drug administration is undermined by status seeking in friendship networks and inadequate trust in health advice networks.

Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, Dunne DW.

Soc Sci Med. 2017 Jun;183:37-47. doi: 10.1016/j.socscimed.2017.04.009. Epub 2017 Apr 8.

29.

Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding.

Lakwo T, Garms R, Wamani J, Tukahebwa EM, Byamukama E, Onapa AW, Tukesiga E, Katamanywa J, Begumisa S, Habomugisha P, Oguttu D, Byamukama E, Richards F, Unnasch TR, Katabarwa M.

Acta Trop. 2017 Mar;167:128-136. doi: 10.1016/j.actatropica.2016.12.029. Epub 2016 Dec 26.

PMID:
28034767
30.

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration.

Crellen T, Walker M, Lamberton PH, Kabatereine NB, Tukahebwa EM, Cotton JA, Webster JP.

Clin Infect Dis. 2016 Nov 1;63(9):1151-1159. Epub 2016 Jul 28.

31.

The Imaramagambo Onchocerciasis Focus in Southwestern Uganda: Interruption of Transmission After Disappearance of the Vector Simulium neavei and Its Associated Freshwater Crabs.

Katabarwa MN, Katamanywa J, Lakwo T, Habomugisha P, Byamukama E, Oguttu D, Nahabwe C, Ngabirano M, Tukesiga E, Khainza A, Tukahebwa E, Unnasch TR, Richards FO, Garms R.

Am J Trop Med Hyg. 2016 Aug 3;95(2):417-425. doi: 10.4269/ajtmh.16-0181. Epub 2016 May 23.

32.

Human eosinophils modulate peripheral blood mononuclear cell response to Schistosoma mansoni adult worm antigen in vitro.

Tweyongyere R, Namanya H, Naniima P, Cose S, Tukahebwa EM, Elliott AM, Dunne DW, Wilson S.

Parasite Immunol. 2016 Aug;38(8):516-22. doi: 10.1111/pim.12336. Epub 2016 Jun 20.

33.

Risk of Intestinal Parasitic Infections in People with Different Exposures to Wastewater and Fecal Sludge in Kampala, Uganda: A Cross-Sectional Study.

Fuhrimann S, Winkler MS, Kabatereine NB, Tukahebwa EM, Halage AA, Rutebemberwa E, Medlicott K, Schindler C, Utzinger J, Cissé G.

PLoS Negl Trop Dis. 2016 Mar 3;10(3):e0004469. doi: 10.1371/journal.pntd.0004469. eCollection 2016 Mar.

34.

Helminths are positively associated with atopy and wheeze in Ugandan fishing communities: results from a cross-sectional survey.

Webb EL, Nampijja M, Kaweesa J, Kizindo R, Namutebi M, Nakazibwe E, Oduru G, Kabubi P, Kabagenyi J, Nkurunungi G, Kizito D, Muhangi L, Akello M, Verweij JJ, Nerima B, Tukahebwa E, Elliott AM; LaVIISWA trial team.

Allergy. 2016 Aug;71(8):1156-69. doi: 10.1111/all.12867. Epub 2016 May 20.

35.

Correction: Influence of Schistosoma mansoni and Hookworm Infection Intensities on Anaemia in Ugandan Villages.

Chami GF, Fenwick A, Bulte E, Kontoleon AA, Kabatereine NB, Tukahebwa EM, Dunne DW.

PLoS Negl Trop Dis. 2015 Dec 4;9(12):e0004287. doi: 10.1371/journal.pntd.0004287. eCollection 2015 Dec. No abstract available.

36.

Comparisons of Allergenic and Metazoan Parasite Proteins: Allergy the Price of Immunity.

Tyagi N, Farnell EJ, Fitzsimmons CM, Ryan S, Tukahebwa E, Maizels RM, Dunne DW, Thornton JM, Furnham N.

PLoS Comput Biol. 2015 Oct 29;11(10):e1004546. doi: 10.1371/journal.pcbi.1004546. eCollection 2015 Oct.

37.

Influence of Schistosoma mansoni and Hookworm Infection Intensities on Anaemia in Ugandan Villages.

Chami GF, Fenwick A, Bulte E, Kontoleon AA, Kabatereine NB, Tukahebwa EM, Dunne DW.

PLoS Negl Trop Dis. 2015 Oct 29;9(10):e0004193. doi: 10.1371/journal.pntd.0004193. eCollection 2015. Erratum in: PLoS Negl Trop Dis. 2015 Dec;9(12):e0004287.

38.

Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda.

Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, Dunne DW.

Clin Infect Dis. 2016 Jan 15;62(2):200-7. doi: 10.1093/cid/civ829. Epub 2015 Sep 25.

39.

Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.

Chalmers IW, Fitzsimmons CM, Brown M, Pierrot C, Jones FM, Wawrzyniak JM, Fernandez-Fuentes N, Tukahebwa EM, Dunne DW, Khalife J, Hoffmann KF.

PLoS Negl Trop Dis. 2015 Jul 6;9(7):e0003920. doi: 10.1371/journal.pntd.0003920. eCollection 2015.

40.

Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.

Nalugwa A, Nuwaha F, Tukahebwa EM, Olsen A.

PLoS Negl Trop Dis. 2015 May 26;9(5):e0003796. doi: 10.1371/journal.pntd.0003796. eCollection 2015 May.

41.

The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial.

Nampijja M, Webb EL, Kaweesa J, Kizindo R, Namutebi M, Nakazibwe E, Oduru G, Kabuubi P, Kabagenyi J, Kizito D, Muhangi L, Akello M, Verweij JJ, Nerima B, Tukahebwa E, Elliott AM; LaVIISWA trial team.

Trials. 2015 Apr 23;16:187. doi: 10.1186/s13063-015-0702-5.

42.

Known Allergen Structures Predict Schistosoma mansoni IgE-Binding Antigens in Human Infection.

Farnell EJ, Tyagi N, Ryan S, Chalmers IW, Pinot de Moira A, Jones FM, Wawrzyniak J, Fitzsimmons CM, Tukahebwa EM, Furnham N, Maizels RM, Dunne DW.

Front Immunol. 2015 Feb 3;6:26. doi: 10.3389/fimmu.2015.00026. eCollection 2015.

43.

Community perceptions, attitude, practices and treatment seeking behaviour for schistosomiasis in L. Victoria islands in Uganda.

Kabatereine N, Fleming F, Thuo W, Tinkitina B, Tukahebwa EM, Fenwick A.

BMC Res Notes. 2014 Dec 11;7:900. doi: 10.1186/1756-0500-7-900.

44.

Effect of water temperature and population density on the population dynamics of Schistosoma mansoni intermediate host snails.

McCreesh N, Arinaitwe M, Arineitwe W, Tukahebwa EM, Booth M.

Parasit Vectors. 2014 Nov 12;7:503. doi: 10.1186/s13071-014-0503-9.

45.

Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children.

Cleland CR, Tukahebwa EM, Fenwick A, Blair L.

Trans R Soc Trop Med Hyg. 2014 Sep;108(9):575-81. doi: 10.1093/trstmh/tru097. Epub 2014 Jul 24.

PMID:
25059523
46.

Suppression of basophil histamine release and other IgE-dependent responses in childhood Schistosoma mansoni/hookworm coinfection.

Pinot de Moira A, Fitzsimmons CM, Jones FM, Wilson S, Cahen P, Tukahebwa E, Mpairwe H, Mwatha JK, Bethony JM, Skov PS, Kabatereine NB, Dunne DW.

J Infect Dis. 2014 Oct 15;210(8):1198-206. doi: 10.1093/infdis/jiu234. Epub 2014 Apr 29.

47.

Evaluation of circulating cathodic antigen (CCA) urine-cassette assay as a survey tool for Schistosoma mansoni in different transmission settings within Bugiri District, Uganda.

Adriko M, Standley CJ, Tinkitina B, Tukahebwa EM, Fenwick A, Fleming FM, Sousa-Figueiredo JC, Stothard JR, Kabatereine NB.

Acta Trop. 2014 Aug;136:50-7. doi: 10.1016/j.actatropica.2014.04.001. Epub 2014 Apr 12.

PMID:
24727052
48.

Human IgE responses to different splice variants of Schistosoma mansoni tropomyosin: associations with immunity.

Silas S, Fitzsimmons CM, Jones FM, Pinot de Moira A, Wawrzyniak J, Tukahebwa EM, Dunne DW.

Int J Parasitol. 2014 May;44(6):381-90. doi: 10.1016/j.ijpara.2014.02.004. Epub 2014 Mar 19.

49.

A latent Markov modelling approach to the evaluation of circulating cathodic antigen strips for schistosomiasis diagnosis pre- and post-praziquantel treatment in Uganda.

Koukounari A, Donnelly CA, Moustaki I, Tukahebwa EM, Kabatereine NB, Wilson S, Webster JP, Deelder AM, Vennervald BJ, van Dam GJ.

PLoS Comput Biol. 2013;9(12):e1003402. doi: 10.1371/journal.pcbi.1003402. Epub 2013 Dec 19.

50.

A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community is required for association with highly prevalent organ related morbidity.

Tukahebwa EM, Magnussen P, Madsen H, Kabatereine NB, Nuwaha F, Wilson S, Vennervald BJ.

PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2268. doi: 10.1371/journal.pntd.0002268. Print 2013.

Supplemental Content

Loading ...
Support Center